TY  - CHAP
M1  - Book, Section
TI  - Drug-Induced Ophthalmic Disorders
A1  - Gosser, Rena
A2  - DiPiro, Joseph T.
A2  - Yee, Gary C.
A2  - Posey, L. Michael
A2  - Haines, Stuart T.
A2  - Nolin, Thomas D.
A2  - Ellingrod, Vicki
Y1  - 2020
N1  - 
T2  - Pharmacotherapy: A Pathophysiologic Approach, 11e
AB  - KEY  CONCEPTS  The  eye  is  highly  susceptible  to  drug  toxicity  due  to  its  extensive  vasculature.  When  ophthalmic  disorders  occur,  all  medications  and  biologic  agents,  irrespective  of  route  of  administration,  are  potential  causes.  It  is  difficult  to  fully  quantify  the  incidence  of  drug-induced  ophthalmic  disorders  due  to  the  variety  of  causative  factors  and  side-effect  reporting  behaviors  of  clinicians.  The  most  common  drug-induced  ophthalmic  disorders  include  dry  eye,  cataract,  intraoperative  floppy  iris  syndrome,  optic  neuropathy,  and  retinopathy.  The  severity  of  drug-induced  ophthalmic  disorders  varies  and  depends  on  dose,  pharmacokinetics,  genetic  predisposition,  age,  extremes  of  body  weight,  and/or  duration  of  exposure.  Health  professionals  and  patients  should  discuss  potential  drug-induced  ophthalmic  disorders  to  ensure  awareness,  prompt  identification,  management,  and  treatment.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/19
UR  - accesspharmacy.mhmedical.com/content.aspx?aid=1182453332
ER  -